Inhibition of Phorbol Ester-induced Mouse Skin Tumor Promotion and COX-2 Expression by Celecoxib: C/EBP as a Potential Molecular Target

참고문헌 (25)

1. "Chronic inflammation: a common and important factor in the pathogenesis of neoplasia", 56, pp.69~83 (2006)
2. "Eicosanoids and multistage carcinogenesis in NMRI mouse skin role of prostaglandins E and F in conversion first stage of tumor promotion second stage of tumor promotion", carci(genesis), pp.91~6 (1989)
3. "Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis", 99, pp.12483~12488 (2002)
4. "Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis", 62, pp.3395~3401 (2002)
5. "Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis", 27, pp.328~336 (2006)
6. "Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation", 24(genesis), pp.1515~1524 (2003)
7. "The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis", 342, pp.1946~1952 (2000)
8. "Signal transduction pathways regulating cyclooxygenase-2 expression", 68, pp.1089~1100 (2004)
9. "Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin", 25(genesis), pp.713~722 (2004)
10. "Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer", 15, pp.21~25 (2006)
11. "Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells", 69, pp.512~519 (2006)
12. "VEGF inhibitors in cancer therapy", 12, pp.387~394 (2006)
13. "Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT", enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues, 1998, pp.273, 27686~27694
14. "Non-steroidal anti-inflammatory drugs for cancer prevention", 6, pp.130~140 (2006)
15. "Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs", 54, pp.1378~1389 (2006)
16. "Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk", 29, pp.621~632 (2006)
17. "COX-2 inhibitors and the heart: are all coxibs the same?", 82, pp.242~245 (2006)
18. "Cyclooxygenase-2 inhibitors", 21, pp.660~664 (2005)
19. "Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke", 37, pp.1725~1730 (2006)
20. "Signal transduction network leading to COX-2 induction", 28, pp.1~15 (2005)
21. "Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors", 98, pp.736~747 (2006)
22. "Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity", 64, pp.2030~2038 (2004)
23. "Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage", 47, pp.1149~1160 (2006)
24. "Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element", 270, pp.24965~24971 (1995)
25. "Inhibition of lipopolysaccharide- induced cyclooxygenase-2 transcription by 6-(methylsulfinyl) hexyl isothiocyanate, a chemopreventive compound from Wasabia japonica (Miq.) Matsumura, in mouse macrophages", 70, pp.1772~1784 (2005)

관련 논문AI추천